Skip to content
Ångström AI logo

Ångström AI

Ångström AI is a YC Summer 2024 (S24) company. Based in San Francisco, CA, USA. Team of 5.

  • AI-powered Drug Discovery
  • Artificial Intelligence
  • Biotech
  • Drug discovery
  • AI

About Ångström AI

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Ångström AI builds physics-constrained generative AI simulations that predict molecular properties, such as solubility, lipophilicity, and crystal structure stability, with accuracy matching wet lab experiments. Pharma and biotech companies use these simulations to evaluate drug candidate efficacy and safety during pre-clinical development, replacing slow and costly laboratory experiments. The underlying models are trained to obey physical laws, eliminating the hallucinations that undermine unconstrained generative AI approaches.

Business model

Pilot project fees paid by pharma customers per engagement.

Go-to-market

Pharma and biotech companies are the direct customers, engaged through pilots focused on specific pre-clinical tasks such as solubility estimation in drug development pipelines.

From the Y Combinator listing

How Ångström AI describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Gen AI molecular simulations that reproduce wetlab results

Angstrom AI builds GenAI-based molecular simulations to substitute wet lab experiments in the pre-clinical drug development pipeline. We are a team of 2 PhD's and 2 Professors from the University of Cambridge who decided to start a company together after we realised how to combine breakthoughs in our research in quantum-accurate models of physics and generative AI models. Our Biotech/Pharma clients can verify the efficacy and safety of new drug candidates using our computer simulations, which match the accuracy of wet lab experiments, but are over 100x faster. We achieve this accuracy by constraining our genAI-based simulations to obey the laws of physics, avoiding the hallucinations seen in other GenAI technologies. Since joining YC, Angstrom AI has developed the first physically accurate gen-AI based simulation of multiple molecules interacting. We have published the first molecule water solubility results with accuracy within the error range of wet lab experiments. We have also kicked-off a 150K pilot project with a pharma company to apply our tech to estimating solubility in their drug development pipeline.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA
Team size
5
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works